Guy Aymard
- Virology top 5%
- HIV Research and Treatment 8
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 3
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 3
- Ophthalmology top 5%
-
- Pharmacology and Obesity Treatment 3
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Vitamin K Research Studies 3
-
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- Philippe LechatB. DiquetN. Costedoat‐ChalumeauBertrand DiquetZahir AmouraA. MahéJean-Marie DangouFatimata Ly
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)British Journal of Clinical Pharmacology (2 papers)American Journal of Nephrology (1 paper)
- Partner nations
- FranceUnited StatesBrazil
In The Last Decade
Guy Aymard
35 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 124
- Virology 179
- Rheumatology 399
- Critical Care and Intensive Care Medicine 120
- Infectious Diseases 361
- Ophthalmology 172
Countries citing papers authored by Guy Aymard
This map shows the geographic impact of Guy Aymard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Aymard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Aymard more than expected).
Fields of papers citing papers by Guy Aymard
This network shows the impact of papers produced by Guy Aymard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Aymard. The network helps show where Guy Aymard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guy Aymard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 147 | |
| 2 | 2010 | 15 | |
| 3 | 2008 | 33 | |
| 4 | 2007 | 14 | |
| 5 | 2006 | 218 | |
| 6 | 2006 | 26 | |
| 7 | 2004 | 9 | |
| 8 | 2003 | 40 | |
| 9 | 2003 | 68 | |
| 10 | 2003 | 17 | |
| 11 | 2003 | 7 | |
| 12 | 2002 | 15 | |
| 13 | 2001 | 20 | |
| 14 | 2000 | 8 | |
| 15 | 2000 | 159 | |
| 16 | 2000 | 79 | |
| 17 | Etude de stabilité d’un collyre à la vancomycine à 50 mg/ml | 1999 | 2 |
| 18 | Stability of vancomycin eye drops | 1999 | 5 |
| 19 | 1998 | 7 | |
| 20 | 1997 | 77 |
About Guy Aymard
Guy Aymard is a scholar working on Virology, Infectious Diseases, Pharmacology, Pharmacology and Emergency Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers), Pharmacology and Obesity Treatment (3 papers), Vitamin K Research Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers), HIV/AIDS Research and Interventions (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Virology (179 citations), Rheumatology (399 citations), Critical Care and Intensive Care Medicine (120 citations), Infectious Diseases (361 citations) and Ophthalmology (172 citations). Guy Aymard has collaborated with scholars based in France, United States and Brazil. Frequent co-authors include Philippe Lechat, B. Diquet, N. Costedoat‐Chalumeau, Bertrand Diquet, Zahir Amoura, A. Mahé, Jean-Marie Dangou, Fatimata Ly, Jean‐Sébastien Hulot and B. Wechsler. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, British Journal of Clinical Pharmacology, American Journal of Nephrology, Annals of Internal Medicine and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.